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1011-141 Left Ventricular Hypertrophy Induces an Increase in N- 
Terminal Pro-Brain Natriuretic Peptide Levels in 
Subjects With and Without Hypertension: A Population 
Study 
Miauel Rivera, Fernando Garcia de Burgos. Francisco Sogorb, Vicente Mire, Vicente 
Betomeu, Antonio Salvador, Rafael Paw. Juan Cosrn, Guillermo Grau. Aleiandro 
Jordan. Vicente Climent, Jose Luis Bosca, Jose Luis Diago. Araceli Frutos, Luis Mainar, 
Vicente Mora, Alrcia Ibahez, Juan Moreno. Jose Valencia, Roberto Elosua. lldefonso 
Roldan, Ricardo Gomez, Grupo Disfuncion VI, Hospital La Fe, Valencia, Spain 
Background: Plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) may be use 
ful in the diagnosis of head failure. Recently it has been published that hypertension (HT) 
must be taken Into account when using NT-proBNP, but left ventricular hypenrophy 
(LVH) without HT could be a cause of NT-proBNP elevation. In a multicenter populatron 
study we compared NT-proBNP in subjects with hypedrophy. with and without the diag- 
nosis of hypertension. 
Methods: We studied 215 subjects (119 females, 96 males), age 6&9, (45-66), 
obtained from a random sample of 432 people from the Valencian Community Spain, 
who in a previous questionnaire had declared to suffer from some degree of dyspnea. 
These 432 subjects were referred to their local hospital (10 hospitals were involved rn the 
study) where blood samples were taken, an echo-Doppler study was performed, a spe- 
cific questionnaire was completed which included the question asking if they had previ- 
ously been diagnosed with HT. Blood samples were all measured independently at the 
same hospital. Out of the 432 subjects, we got a positwe answer from 215, and 49 have 
LVH (LV mass index z-125 gr/mz). NT-proBNP levels are in pg/ml, mitral flow propagation 
velocity (VP) in cm/s, LV mass index in gr/mz, and blood pressure in mercury mm. 
Results: For the whole LVH population NT-proBNP was 201*212, LV mass index 
172*55, Vp 53*19 and ejection fractron (EF) 63i9. When we compared NT-proBNP 
(197+207) in sublects without diagnostic of HT (n=23. age 69&3, systolic blood pressure 
141*20, diastolic blood pressure 80*7. LV mass index 173+72, Vp 50+18, EF 62*8) with 
NT-proBNP (205*220) in subjects with diagnostic of HT (n=26, age 70+5, systolic blood 
pressure 16Oi24, diastolic blood pressure 90210, LV maas index 172i37, Vp 56*20, EF 
63alO). we found NS. 
Conclusion : This population study shows that NT-proBNP is elevated in patients with 
LVH with or without HT. In LVH the presence of HT does not rnfluence the peptrde levels 
significantly. This should be confirmed in new studies for its potential importance when 
using NT-proBNP for diagnostic and prognostic purposes. 
loll-142 The 994T Allele of the Endothelial Nitric Oxide Synthase 
Gene Is Related to Left Ventricular Mass in African 
Americans With High-Normal Blood Pressure 
Riaoberl Law-Bula, Alexander Quarshte, Deborah Lyn, Adefisayo Oduwole, Cheryl 
Pack, Jan Morgan, Pnscilla Igho-Pemu, Rongling Li, Elizabeth Ofili. Morehouse School 
of Medicine, Atlanta, GA 
Background: The 894T allele of a single base exchange polymorphism (G894T) in exon 
7 of the endothelial nitric oxide synthase (eNOS) gene has been recently associated with 
hypertension (HTN) in some but not all studies. Because high-normal blood pressure 
(BP) confers an increased risk for the development of HTN and other cardiovascular dis- 
orders, including left ventricular hypertrophy (LVH), we tested the hypotheses that the 
allelic variation (894T) in the eNOS gene would directly correlate with alterations in LV 
mass (LVM) in individuals with high-normal BP. 
Methods: Genotype distributron or allele frequencies of G894T were compared between 
13 African Americans with high-normal BP (systolic BP of 130 to 139 and/or diastolrc BP 
of 85 to 89 mmHq) and 44 counteroarts with normal BP (cl3Ol85 mmHo). Echocardio- _. “, 
graphic LVM was calculated (Devereux formula) and indexed to body surface area to 
define the oresence of LVH (LVMI >134/110 aim2 for men/women). 
Results: Among individuals wrth hrgh-normal BP, homozygous carriers of the 894T allele 
(TT) had higher LVMI than heterozygous GT and mdividuals without 894T allele (i.e., 
GG) (205217 vs. 70+25 and 91+18 g/rn2, respectively, P<O.OOl). In contrast, no such dif- 
ference was observed rn individuals with normal BP for TT carriers as compared with GT 
and GG (84*12 vs. 78~24 and 63*24 g/m’, respectwely, P=NS). This relationship whrch 
was observed between eNOS 894T allele and LVMI in individuals with hrgh-normal BP, 
but not in those with normal BP, was also observed in analysis of variance (ANOVA) 
model after adjusting for age, gender, body mass index and smoking. Conclusion: 
These findings suggest a relationshlp between the G894T polymorphic variant of the 
eNOS gene and LV mass in African Americans wth high-normal blood pressure. 
1011-143 Relations of Ethnicity and Vascular Parameters to Lefl 
Ventricular Structure in Hypertensive Adults 
Joroe Ft. Kizer, Donna K. Amen Jonathan N. Bella, Mary Paranicas. D. C. Rae, Michael 
A. Province, Albert Oberman, Dalane W. Kitzman, Paul N. Hopkins, Mary J. Roman, 
Richard B. Devereux, Weill Medical College of Cornell University, New York, NY, 
University of Minnesota School of Medicine, Mrnneapolis, MN 
The impact of systemic hemodynamics and arterial stiffness on ethnic differences in left 
ventricular (LV) anatomy has not been explored. We evaluated black-white differences in 
LV structure, hemodynamics and arterial stiffness in 1693 hypertensive adults in the 
HyperGEN Study. Clinical characterrstics. includmg standardized blood pressure (BP) 
measurements, were obtained during a clinrc visit. Transthoracic echo was performed 
according to a standardized protocol. LV hypenrophy was defined as LV mass ) 51 kg/ 
ms 7 and increased relative wall thickness (RWT) as, 0.43. Doppler-derived stroke vol- 
urna and cardiac index, together with BP measured at echo, were used to calculate pulse 
pressure/stroke index (PP/SI), a measure of arterial stiffness, and peripheral resistance 
index (PRI). After adlustment for age, sex, body size. diabetes mellitus, clinic BP, dura- 
tion of hypertension and medrcations, LV mass and RWT were significantly greater in 
blacks. Systolic and diastolic BP at echo exceeded average cknic values in both groups. 
but blacks showed a markedly greater increase in diastolic BP than whites. PRI deter- 
mined at echo was also higher in blacks, but cardiac index was similar, indicatmg an 
increase in vascular tone. PP/SI was instead higher in whites. In multrple linear ragres- 
sion analyses, both cardiac index and PAI, but not sthnicity, were significant independent 
correlates of LV mass in the entire cohort, whereas black ethnicity, PRI and PPISI were 
independently associated with RWT. Upon multivariable adjustment that included clinic 
BP, arterial stiffness and hemodynamics, black ethnicity ceased to be Independently 
associated with the presence of LV hypertrophy (OR, 0.94; 95% Cl, 0.62-1.43) but 
remained strongly and significantly related to increased RWT (OR, 2.32; 95% Cl, 1.20. 
4.47). Our findings demonstrate a strong assocration between black ethnicity and 
increased RWT and show that vascular reactivity and hemodynamics are important cor- 
relates of black-white differences in LV mass in hypertension Research specifically 
examining patterns of BP and vascular tone reactivity should improve understanding of 
ethnic disparities in hypertensive organ damage. 
1011-144 Gender Differences in Regression of 
Electrocardiographic Left Ventricular Hypertrophy in 
Response to Antihypertensive Therapy: The LIFE Study 
Peter M. Okin, Richard 8. Devereux, Sverker Jern. Sverre E. Kjeldsen, Steve Julius. 
Bjom Dahlof, for the LIFE Study Investigators, Weill Medical College of Cornell 
University, New York, NY 
Background: Men and women have well-established drfferences rn the magnitude of 
ECG left ventricular hypertrophy (LVH). However, whether there are gender differences 
in the degree of regression of ECG LVH in response to antihypertensive therapy IS 
unclear. 
Methods 9193 hypertensive patients (4,963 women and 4,230 men) in the LIFE study 
were treated with losartan- or atenolol-based regimens and followed with serial ECG and 
blood pressures (BP) yearly untrl death or study end. ECG LVH was measured using 
gender-adjusted Cornell voltage-duration product (CP) ([RVvL+Svs(+6 mm in 
women)J’QRS duration) and using Sokolow-Lyon voltage (SL) criteria: CP ~2,440 
rnnwnsec or SL 238 mm defined the presence of LVH. Changes in CP and SL were 
measured from baseline to last in-study wsit. 
Results’ At study baseline, compared with men. women ware older, less likely to be 
black, had higher systolic but lower diastolic BP. higher CP (2,924*1027 vs 2,716*1,065 
rnnwnsec, pc.001) and a higher prevalence of LVH by CP (69.0 vs 62.1%, p<.OOl), but 
lower SL 28.2A9.8 vs 32.2+10.9 mm. p<.OOl) and a lower prevalence of SL LVH (15.8 vs 
28.9%, p<.OOl). After a mean follow-up of 4&0.9 years, women had less reduction in 
CP (-167+797 vs -272&46 rnnwnsac, p<.OOl) and rn SL (-3.le6.6 vs -4.9e7.6 mm, 
pc.OOl), and smaller reductions in the prevalence of LVH by CP (-14.7 vs -19.0%, 
pc.001) and SL (-6.1 vs -14.9% p<.OOl), with slightly smaller reductions in systolic (- 
29.3+20.0 vs -3O.Ot19.0 mm Hg, p=.O56) anddiastolic BP (-16&9.5 vs -17.5klO.4 mm 
Hg, p=.OOl). After controlling for baseline gender differences, for small In-study gender 
differences in change in BPS and for treatment with losanan vs atenolol, women had srg- 
nificantly less reduction in CP (adjusted mean change -107 vs -310 rnnwnsac, p<O.OOl) 
and in SL (-3.1 vs -3.8 mm, p=O.O13). 
Conclusion: Hypertensive women have less regressron of ECG LVH than men by both 
CP and SL criteria, independent of baseline gender differences in severity of ECG LVH 
and after taking into account treatment effects. These findings suggest that gender differ- 
ences rn ECG LVH changes may need to be taken into account when assessing the rela- 
tron of changes in CP and SL to outcome. 
1011-145 The Influence of Body Weight on Blood Pressu \ 
Response to Exercise in Patients With Normotensive 
ABPM Values 
lnoomar W. Franz. Joachim F. M. Mueller, Clinic Wehrawald (BfA), Todtmoos, Germany 
Background: A hypertensive blood pressure (BP) response IS known as a more reliable 
predictor for LVH and cardiovascular mortality compared to casual BP. Obese patients 
have an increased cardrovascular risk. One reason could be a hypertensive BP response 
only during exercise. 
Methods: 1466 persons underwent an ABPM and a group of 557 (f: 317, m: 240, age: 
48.7*11.7y.) was identified as normotensive (daytime<1 35/s65mmHg, SpaceLabs 
90207). All patients underwent standardized ergometry (50.loowatts, 5 min recovery 
period), echocardiography and were finally arbitrarily divided into 3 groups according to 
therr EIMI (table). 
Results: Despite clear normotensive BP values during ABPM and comparable heart 
rates, the percentage of patients with a hypertensive BP response during ergometry 
(ExBP+, >2001>100 mmHg at 100 watts) increased significantly (pcO.001) according to 
their increased BMI and was accompankad by a signrficantly (p-zO.01 - pcO.001) higher 
LVMI compared to patients with normal exercise BP (ExBP-). 
n=557 G,, BMI ~25, n=149 G,, BMI 25 30. n=222 G,. BMI >30, n=l86 
X+lS 
ExBP- ExBP+ ExBP- ExBP+ ExBP- ExBP+ 
n= 117(78.5 32(21.5%) 101(45.5 121(54.5 23(12.4%) 163(87.6% 
%) %) %) ) 
ABPM-24h 117.2+7/ 123.9*5/ 117.7*7 / 120.7+6/ 119.0+6 I 122.&7/ 
(mmHg) 73.6~7 78.8+3 74.3*5 76.9*4 72.6~6 76.8+5 
ExBP-1 OOw 173*24 / 216*15/ 180+24/ 217*19/ 188+22 / 222*21 / 
WW 88111 110+9 91*11 113*9 95*13 116k.12 
LVMl(s/ms) 67.4+19 79.4+12 72.9il9 868~21 74.4*14 86.2il9 
BMl(kg/ms) 22.&f .8 23.&i .O 26.911.4 27.5*1.4 32.5k2.3 34.lk3.5 
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Patients with increased ExBP showed significantly higher (~~0.05 - 0.001) Idl-cholesterol 
and triglyceride levels and significantly lower hdl-cholesterol levels. 
Conclusions: Despite normotensive BP during ABPM. obese patients frequently show a 
pathologically increased BP response during standardized ergometry. This increased BP 
response to exercise has an influence not only on LVMI, but also on cardiovascular mor- 
tality, and should therefore be assessed in obese patients. 
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1032-120 Expression of NAD(P)H Oxidase Components in Human 
Platelets 
Naglaa A. ECSherbeeny, Lawrence T. McGrath. Lana J. Dixon, Siobhan Brennan, @y 
E. McVeiah Queen’s University Belfast, Belfast, United Kingdom 
Background. Nitric oxide (NO) is involved in vasodilation. This is related to the bioavail- 
ability of NO, rather than absolute production. A major scavenger of NO is the superoxide 
anion which is released by endothelial and vascular smooth muscle cells. Platelets 
release both NO and superoxide and share many pathways found in endothelial cells. 
We examined human platelets for components of of the superoxide generating system, 
NAD(P)H oxidase. Methods. Platelets and leukocytes were prepared by sequential cen- 
trifugation and lysed in buffer containing n-octyl-D-glucopyranoside (ODG). Early pas- 
sage human aortic endothelial cells (HAECs) were cultured until confluence, washed and 
lysed in ODG containing buffer. Standardised amounts of each lysed cell type were anal- 
ysed by SDS-PAGE and Western blotting using anti gp 91 phox and anti racl primary 
antibodies and visualised by enhanced chemiluminescence. Results. We demonstrated 
gp 91 phox and RX 1 in human platelets in amounts equal to or greater than that found 
in cultured human HAECs. These componets of NAD(P)H oxidase were found in all sam- 
ples of platelets examined (n=lO). Conclusion. Other workers have demonstrated the 
am- 
ma- 
presence of p22 phox and ~67 phox which along with our observations comprise the 
major components of NAD(P)H oxidase found in human endothelial cells. We suggest 
this makes isolated platelets a suitable model to study changes in endothelial cell super- 
oxide pathway components in response to various interventions. 
1032-121 Binding of FVlla to TF Promotes Smooth Muscle Cell 
Proliferation In Vitro via Activation of the Extracellular 
Regulated Kinases 
Plinio Clnllo, Paolo Golino, Paolo Calabro, Gaetano Cali, Lavinia Forte, Salvatore De 
Rosa, Mario Pacileo, Francesco Scopacasa. Massimo Chiariello, University of Naples, 
Naples, Italy, 2nd University of Naples, Naples, Italy 
&stenosis following PTCA recognizes smooth muscle cell (SMC) prokferation as a key 
event. However, the mechanisms involved are not completely known. Tissue Factor (TF), 
a transmembrane glycoprotem. forms a complex with factor VII (FVII), thus activating the 
coagulation pathway. However, TF may function also es a membrane receptor and we 
have previously shown that binding of activated FVII (FVlla) to TF induces SMC prolifer- 
ation. In the present study we assessed whether this phenomenon is the result of activa- 
tion of the extracellular signal regulated kinase (ERK) pathway. SMCs from rabbit aortas 
were made quiescent by serum deprivation. After 24 hrs, SMCs were stimulated with 
FVlla (100nM) and orocessed for total orotein isolation at baseline (no stimulation). and ,. 
after 1, 2, 5, 15. 20. 30 and 60 min following stimulation. Phosphorylation (activation) of 
ERKs (oERKs) was assessed bv immunoblottina usino anti-oERK antibodv. To better _ _ 
define the role of PERK in SMC proliferation, in additional experiments, SMCs were pre- 
incubated with UO126 (IOpM), an inhibitor of ERK phosphorylation; SMCs were stimu- 
lated with FVlla as above and proliferation (thymidine incorporation) and ERK 
phosphorilation (immunoblotting) evaluated. SMC proliferation appeared to be related to 
ERK activation. as suggested by the observation that UO126 inhibited it. This effect was 
associated with the inhibition (delay) of ERK phosphorilation. Thus, TF/FVlla complex 
leads to SMC proliferation via activation of ERKs. 
KKK - PlroMlbaciblni 
ep*- 
1032-l 22 The Molecular Mechanisms of Calcium Dependent 
Tissue-Type Plasminogen Activator Release 
James A. Muldownev. Ill, Corrie A. Palmer, Elaine Sanders-Bush, Nancy J. Brown. 
Douglas E. Vaughan, Vanderbilt University Medical Center, Nashville, TN 
Physiologic release of tissue-type plasminogen activator (t-PA) from the endothelium is 
critical for vascular homeostesis. Atherosclerosis and cigarette smoking impair coronary 
release of t-PA. Thrombin-induced t-PA release is a g-protein coupled, calcium-depen- 
dent phenomenon. S is the g-protein primarily responsible for GPCR-dependent csl- 
cium signaling. In this study, we tested the hypothesis that thrombin-induced t-PA 
release is a $, phospholipase-CD (PLCp), and inositol-triphosphate (IP&dependent 
phenomenon. Human microvascular endothelial cells were incubated with2mM sodium 
butyrate for 24 hours. Cells were washed and incubated for 30 minutes in Ml99+0.03% 
albumin and inhibitors in triplicate. Cells were stimulated with 10 U/ml thrombin, agonist, 
or vehicle. Medium was harvested at 0 and 5 minutes, and t-PA antigen was measured 
by ELISA. Cells were pretreated with a decoy peptide identical to the $ c-terminus 
linked to a membrane permeable sequence (MPS-Gd prior to thrombin treatment. A 
peptide containing the 4 sequence was a negative control (MPS-&). Separately, cells 
were stimulated with Pasteurella multocidia toxin (rPMT), a G, agonist. MPS-G, obliter- 
ated thrombin induced t-PA release while MPS-C, did not. Treatment with rPMT, trended 
towards induction of t-PA release at 140 pM. Thrombin-induced t-PA release was inhib- 
ited in a dose-dependent manner by U73122, a PLCQ antagonist (lC,=@M). U73343, 
an inert analog, had no effect. The I& receptor antagonist P-APB also inhibited throm- 
bin-induced t-PA release in a dose-dependent manner (IC&+OpM). Thrombin-induced 
t-PA release in human endothelial cells is $, PLCp. and IPs-dependent. Acquired 
impairment of coronary t-PA release in smokers may involve alterations in one or more 
messengers in this pathway, which may partially explain the increased risk of coronary 
thrombosis in these groups. 
1032-123 Altered Balance of Matrix Metalloproteinase and Tissue 
Inhibitor of Metalloproteinase in Human Atherosclerotic 
Plaque: Evidence From Quantitative Analysis of Gene 
Expression Using Real-Time FIT-PCR Method 
Takeo Hiaashikata, Masakezu Yamagishi. Toshio Higashi, lzumi Nagata, Aiji Sakamoto, 
National Cardiovascular Center Research Institute. Suita, Japan, National 
Cardiovascular Center, Suita. Japan 
Background: Although gene expression survey for atherosclerotic lesion has been 
recently conducted by cDNA array, few data exist regarding quantitative measurement of 
key genes in human atherosclerotic tissue. We developed an efficient procedure that 
makes it possible to quantitate expression levels of various genes in the scarce amount 
of human tissue available. And we tested a hypothesis that altered expression balance of 
matrix metalloproteinases (MMPs) to tissue inhibitors of metalloproteinase (TIMPs) plays 
a pivotal pathogenetical role in human atherosclerosis. 
Methods: Samples of the plaque shoulder region and minimally affected intima were 
obtained from atherosclerotic carotid arteries in 24 patients with carotid endoatterec- 
tomy. Total RNA was extracted from the samples and subjected to cDNA synthesis with 
random primer. Amount of the cDNAs for MMP-I, 2, 3 and 9. and TIMP-I, 2, 3 and 4 in 
each cDNA mixture were determined by real-time RT-PCR method using ABI 7700 
sequence detection system (Appliedbiosystams), and normalized with that of GAPDH 
(glutsraldehyde 3-dehydrogenase) as a reference gene. 
Results: Total RNA (0.49*0.22pg) was successfully extracted from small amount of the 
human samples weighing 11.7*2.64mg, which was adequate for cDNA synthesis. In 
shoulder region, the genes for MMP-1 (1.27+~0.27) and MMP-9 (2.2OkO.55) were signifi- 
cantly augmented than those in minimally affected intima (0.30~0.12 and 0.62+0.24. 
respectively, pcO.01). Also, the expression levels of TIMP-1 and TIMP-3 genes were 
higher in shoulder region (1.22*0.22 vs. 0.61+0.47, and 0.47r0.12 vs. 0.26*0.09, 
respectively). The indices of MMP-ITTIMP-1 and MMP-S/TIMP-1 were 2.6 and 4.5 times 
higher in plaque shoulder region than in minimally affected intima. 
Conclusion: Upregulation of MMPs in plaque shoulder region was disproportional to that 
of TIMPs, suggesting that active degradation of extracellular matrix persists in advanced 
atherosclerotic lesion. We consider that quanbtative measurement of gene expression 
with the present method in human atherosclerotic tissue gives us deep understanding for 
its pathogeneses. 
1032-124 Fibrinolytic Activity and Protein Gene Polymorphisms: 
Association With Coronary Artery Disease 
Raymond L. Benz+. University of Alabama at Birmingham, Birmingham, AL 
Background: Impaired fibrinolytic activity (FA) is associated with atherosclerosis and 
may be determined, in part, by specific fibrinolytic protein (FP) gene polymorphisms 
(PM@, yet interrelationships between these PMs, Fas , and clinical atherosclerosis 
remain unclear. We determined whether associations existed between FP gene PMs, FP 
